Type 1 Diabetes Clinical Trials in Kansas City, Missouri

4 studies are recruiting for type 1 diabetes in Kansas City, Missouri right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

    This study is a Phase 1b/2a First-in-Human (FIH) clinical trial to assess the safety, tolerability, pharmacodynamics (PD), and efficacy of multiple ascending doses of CNP-103. The approximately 393-days study consists of a Screening Period (28 days), Treatment Period (90 days), and Post-Dose Evalua…

    Stage
    Phase 1
    Ages
    12 to 35
    Site
    Children's Mercy Hospital, Kansas City, Missouri
    Locations
    45 in total
    Run by
    COUR Pharmaceutical Development Company, Inc.

    See if you can join NCT06783309 on ClinicalTrials.gov

  2. Remedy to Diabetes Distress (R2D2): A Scalable Screen to Treat Program for School-age Families

    This R01 is in response to RFA-DK-19-021, Treating Diabetes Distress to Improve Glycemic Outcomes in Type 1 Diabetes. The objective is to test the feasibility and acceptability of a novel, practical, and potentially scalable screen to treat program for diabetes distress in families of school-age ch…

    Stage
    Not phased
    Ages
    8 to 65
    Site
    Children's Mercy Kansas City, Kansas City, Missouri
    Locations
    2 in total
    Run by
    Nemours Children's Clinic

    See if you can join NCT05268250 on ClinicalTrials.gov

  3. SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes

    This is a Phase 2b, investigator- and participant-blinded, placebo-controlled, parallel-arm study to evaluate the efficacy, safety and tolerability of SAB 142 in patients with Stage 3 New Onset of Type 1 Diabetes (NOT1D).

    Stage
    Phase 2
    Ages
    5 to 40
    Site
    Children's Mercy Hospital Kansas City - Pediatric Care Clinic, Kansas City, Missouri
    Locations
    70 in total
    Run by
    SAb Biotherapeutics, Inc.

    See if you can join NCT07187531 on ClinicalTrials.gov

  4. Registry for Stage 2 Type 1 Diabetes

    Stage 2 Type 1 Diabates (T1D) is an early stage of T1D characterized by dysglycemia but not yet leading to clinical symptoms. Progression of the disease to Stage 3 (clinical T1D), leads to overt hyperglycemia requiring eventually exogenous insulin. TZIELD® (teplizumab-mzwv) has been approved to del…

    Stage
    Not phased
    Ages
    Any age
    Site
    Children's Mercy Adelle Hall Campus- Site Number : 8400014, Kansas City, Missouri
    Locations
    37 in total
    Run by
    Sanofi

    See if you can join NCT06481904 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.